Северного Кавказа
по надзору за соблюдением законодательства
в сфере массовых коммуникаций
и охране культурного наследия
ПИ №ФС77-26521 от 7 декабря 2006 года
ISSN 2073-8137
русский
english
Поиск по сайту
Адрес редакции
355017, Ставрополь, улица Мира, 310.
Телефоны
(8652) 35-25-11, 35-32-29.
E-mail
medvestnik@stgmu.ru
Журнал включён в Перечень ведущих рецензируемых научных журналов и изданий, в которых должны быть опубликованы результаты диссертаций на соискание учёной степени кандидата и доктора наук (решение Президиума ВАК Минобрнауки РФ №6/6, февраль 2010).
Журнал включён в Реферативный журнал и Базы данных ВИНИТИ РАН и зарегистрирован в Научной электронной библиотеке в базе данных Российского индекса научного цитирования на основании сублицензионного договора № 07-04/09-14 от 25 марта 2009 года.
Журнал индексируется: БД SCOPUS, Ulrich's International Periodicals Directory.
Значение мелатонина для физиологии и патологии глаза
[Обзоры]
Арушанян Эдуард Бениаминович; Ованесов Карен Борисович;
Мелатонин, основной гормон мозговой железы эпифиза, широко представлен во всех структурах глаза, и прежде всего в сетчатке. Здесь же определяется и высокая плотность специфических мелатониновых рецепторов. С привлечением современных литературных сведений в обзоре обсуждается роль эпифизарного гормона в физиологии и патологии зрительного анализатора, а также перспективы использования его лечебных возможностей в офтальмологии.
Список литературы:
1. Арушанян, Э. Б. Ограничение окислительного стресса как основная причина универсальных защитных свойств мелатонина / Э. Б. Арушанян // Экспер. и клин. фармакол. – 2012. – Т. 75, № 5. – С. 44–49.
2. Арушанян, Э. Б. Мелатонин и сахарный диабет / Э. Б. Арушанян // Проблемы эндокринол. – 2012. – Т. 58, № 3. – С. 35–40.
3. Арушанян, Э. Б. Универсальные терапевтические возможности мелатонина / Э. Б. Арушанян // Клин. мед. – 2013. – № 2. – С. 4–8.
4. Арушанян, Э. Б. Эпифиз в системе зрительного анализатора / Э. Б. Арушанян, К. Б. Ованесов // Успехи физиол. наук. – 1995. – Т. 26, № 3. – С. 25–39.
5. Abe, М. Circadian rhythm of serotonin N-acetyltransferase activity in rat lens / M. Abe, M. T. Itoh, M. Miyata [et al.] // Exp. Eye Res. – 2000. – Vol. 70, № 6. – P. 805–808.
6. Асипа-Castroviejo, D. Extrapineal melatonin: sources, and potential functions / D. Acuna-Castroviejo, G. Escames, C. Venegas [et al.] // Cell. Mol. Life Sci. – 2014. – Vol. 71, № 16. – P. 2997–3025.
7. Agorastos, A. The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential / A. Agorastos, C. G. Huber // J. Pineal. Res. – 2011. – Vol. 50, № l. – P. 1–7.
8. Alarma-Estrany, P. Melatonin receptors in the eye: location, second messengers and role in ocular physiology / P. Alarma-Estrany, J. Pintor // Pharmacol. Ther. – 2007. – Vol. 113, № 3. – P. 507–522.
9. Alcantara-Conteras, S. Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse / S. Alcantara-Conteras, K. Baba, G. Torsini // Neurosci. Lett. – 2011. – Vol. 494, № l. – P. 61–64.
10. Anwar, M. M. The effect of melatonin on eye lens of rats exposed to ultraviolet radiation / M. M. Anwar, M. A. Mustafa // Соmр. Biochem. Physiol. Toxicol. Pharmacol. – 2001. – Vol. 129, № 1. – P. 57–63.
11. Baba, K. Age-related changes in the daily rhythm of photoreceptor functioning and circulatory in a melatonin-proficient mouse strain / K. Baba, F. Mazzoni, S. Owino [et al.] // PLoS One. – 2012. – Vol. 7, № 5. – P. e37799.
12. Baba, K. Melatonin modulates visual function and cell viability in the mouse retina via the MTl melatonin receptor / K. Baba, N. Pozdeyev, F. Mazzoni [et al.] // Proc. Nat. Acad. Sci. – 2008. – Vol. l06, № 35. – P. 15043–15048.
13. Belforte, N. A. Melatonin: a novel neuroprotectant for the treatment of glaucoma / N. A. Belforte, M. C. Moreno, P. H. de Zavalia [et al.] // J. Pineal Res. – 2010. – Vol. 48, № 4. – P. 353–364.
14. Bubenik, G. A. The role of melatonin and dopamine in retinal physiology / G. A. Bubenik, R. A. Purtille // Canad. J. Physiol. Pharmacol. – 1980. – Vol. 58, № 5. – P. 1457–1462.
15. Buonfiglio, D. C. Rat retina robust circadian expression of clock and clock output genes in explant culture / D. C. Buonfiglio, A. Malan, C. Sandu [et al.] // Mol. Vis. – 2014. – Vol. 20. – P. 742–752.
16. Charlton-Perkins, M. Building a fly eye: terminal differentiation events of the retina, corneal lens, and pigmental epithelia / M. Charlton-Perkins, T. A. Cook // Curr. Top. Dev. Biol. – 2010. – Vol. 93. – P. 129–173.
17. Chen, W. Urinary 6-sulfatoymelatonin level in diabetic retinopathy patients with type 2 diabetes / W. Chen, H. Cao, Q. Y. Lu [et al.] // Int. J. Clin. Exp. Pathol. – 2014. – Vol. 7. – P. 4317–4322.
18. Chiou, G. C. Melatonergic involvement in diurnal changes of intraocular pressure in rabbit eyes / G. C. Chiou, T. Aimoto, L. Y. Chiou // Ophtalmic Res. – 1985. – Vol. 17. – P. 373–378.
19. Choi, S. I. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors / S. I. Choi, S. Dadakhujaev, H. Ryo [et al.] // J. Pineal Res. – 2011. – Vol. 51. – P. 94–103.
20. Crooke, A. Effect of melatonin and analogues on corneal wound healing: involvement of MT2 melatonin receptor / A. Crooke, A. Guzman-Aranguez, A. Mediero [et al.] // Curr. Eye Res. – 2014. – Vol. 15. – P. 65–73.
21. Crooke, A. Ocular disorders and the utility of animal models in the discovery of melatoninegic drugs with therapeutic potential / A. Crooke, F. Huete-Toral, A. Martinez-Aguila [et al.] // Expert. Opin. Drug Discov. – 2012. – Vol. 7. – P. 989–1001.
22. Ebadi, M. Pineal and retinal peptides and their receptors / M. Ebadi, T. D. Hekum, R. F. Pfeifer // Pineal Res. Rev. – 1989. – Vol. 7. – P. 1–156.
23. Fornaro, M. Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? / M. Fornaro, F. Bandini, L. Cestari [et al.] // Neuropsychiatr. Dis. Treat. – 2014. – Vol. 10. – P. 907–914.
24. Fu, Y. Anti-apoptotic effects of melatonin in retinal pigment epithelial cells / Y. Fu, M. Tang, Y. Fan [et al.] // Front. Biosci. – 2012. – Vol. 17. – P. 1461–1468.
25. Gagne, A. M. Impact of oral melatonin on the electroretinogram cone response / A. M. Gagne, K. V. Danilenko, S. G. Rosolen // J. Circadian. Rhythms. – 2009. – Vol. 7. – P.14–17.
26. Govitrapong, P. Status of dopamine in bovine pineal gland and stimulation of N-acethyltransferase activity by D2 dopaminergic receptor agonists in the rat pineal gland in culture / P. Govitrapong, T. Hama, R. Pfeifer [et al.] // J. Pineal Res. – 1989. – Vol. 6. – P. 17–25.
27. Gui, M. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats / M. Gui, S. Emre, M. Esrefoglu // Cornea. – 2008. – Vol. 27. – P. 795–801.
28. Hikichi, T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy / T. Hikichi, N. Takeda, T. Miura // Clin. Ophthalmol. – 2011. – Vol. 5. – P. 655–660.
29. Hiragaki, S. Melatonin signaling modulates clock genes expression in the mouse retina / S. Hiragaki, K. Baba, E. Coulson [et al.] // PLoS One. – 2014. – Vol. 9. – P. el06819.
30. Huang, H. Neuromodulatory role of melatonin in retinal information processing / H. Huang, Z. Wang, S. J. Weng [et al.] // Prog. Retin. Eye Res. – 2013. – Vol. 32. – P. 64–87.
31. Itoh, M. T. Expression and cellular localization of melatonin-synthesizing enzymes in the rat lens / M. T. Itoh, N. Takahashi, M. Abe // J. Pineal. Res. – 2007. – Vol. 42. – P. 92–96.
32. Juvone, P. M. Evidence for a D2-dopamine receptor in frog retina that decreases cyclic AMP accumulation and serotonin-N-acethyltransferase activity / P. M. Juvone // Life Sci. – 1986. – Vol. 38. – P. 331–342.
33. Iuvone, M. P. N-acethylserotonin: circadian activation of the BDNF receptor and neuroprotection in the retina and brain / P. M. Iuvone, J. H. Boatright, G. Tosini // Adv. Exp. Med. Biol. – 2014. – Vol. 801. – P. 765–771.
34. Jiang, T. Melatonin-mediated cytoprotection against hyperglycemic injury in Muller cells / T. Jiang, Q. Chang, Z. Zhao [et al.] // PLoS One – 2012. – Vol. 12. – P. e50661.
35. Kaur, С. Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats / C. Kaur, V. Sivakumar, R. Robinson [et al.] // J. Pineal Res. – 2013. – Vol. 54. – P. 190–206.
36. Кiliс, A. Protective effects of melatonin on oxidative-antioxidative balance and cataract formation in rats / A. Kilic, S. Selek, O. Erel // Ann. Ophtalmol. – 2008. – Vol. 40. – P. 22–27.
37. Lassen, N. The role of corneal crystalline in the cellular defense mechanisms against oxidative stress / N. Lassen, W. J. Black, T. Estey // Semin.Cell Dev. Biol. – 2008. – Vol. 19. – P. 100–112.
38. Li, X. Effects of melatonin on streptozotocin-induced retina neuronal apoptosis in high blood glucose rat / X. Li, M. Zhang, W. Tang // Neurochem. Res. – 2013. – Vol. 38. – P. 669–776.
39. Lundmark, P. O. Role of melatonin in the eye and ocular dysfunctions / P. O. Lundmark, S. R. Pandi-Perumal, V. Srinivasan // Vis. Neurosci. – 2006. – Vol. 23. – P. 853–862.
40. McMahon, D. G. Circadian organization of the mammalian retina: from gene regulation to physiology and diseases / M. G. McMahon, P. M. Iuvone, G. Tosini // Prog. Retin. Eye Res. – 2014. – Vol. 39. – P. 58–76.
41. Meng, T. Contralateral retina dopamine decrease and melatonin increase in progression of hemiparkinsonium rat / T. Meng, Z. H. Zheng, T. T. Liu // Neurochem. Res. – 2012. – Vol. 37. – P. 1050–1056.
42. Moreno, M. C. Retinal oxidative stress induced by high intraocular pressure / M. C. Moreno, J. Campanelli, P. Sande [et al.] // Free Radic. Biol. Med. – 2004. – Vol. 37. – P. 803–812.
43. Mykheltseva, I. M. Protective action of melatonin in experimental glaucoma in rats / I. M. Mykheltseva // Fiziol. Zh. – 2013. – Vol. 59. – P. 78–83.
44. Park, S. W. The effect of melatonin on retinal ganglion cell survival in ischemic retina / S. W. Park, H. S. Lee, M. S. Sung // Chonam. Med. J. – 2012. – Vol. 48. – P. 116–122.
45. Ping, Y. Melatonin protects rod signals to ON type bipolar cells in fish / Y. Ping, H. Huang, X. Y. Zhang [et al.] // J.Physiol. – 2008. – Vol. 586. – P. 2683–2694.
46. Quay, W. B. Increases in volume, fluid content, and lens weight of eyes following systemic administration of melatonin / W. B. Quay // J. Pineal Res. –1984. – Vol. 1. – P. 3–13.
47. Rada, J. A. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation / J. A. Rada, A. F. Wiechmann // Invest. Ophthalmol. Vis. Sci. – 2006. – Vol. 47. – P. 25–33.
48. Rastmanesh, R. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity / R. Rastmanesh // Med. Hypotheses. – 2011. – Vol. 76. – P. 79–85.
49. Rohde, B. H. Existence and role of endogenous ocular melatonin / B. H. Rohde, McLaughlin, L. Y. Chiou // J. Ocul. Pharmacol. – 1985. – Vol. 1. – P. 235–243.
50. Rosen, R. B. Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage / R. B. Rosen, D. N. Hu, M. Chen [et al.] // Mol. Vis. – 2012. – Vol. 18. – P. 1640–1648.
51. Ruan, G. X. Divergent roles of clock genes in retinal and suprachiasmatic nucleus circadian oscillators / G. X. Ruan, K. L. Gamble, M. L. Risner [et al.] // PLoS One. – 2012. – Vol. 7. – P. e38985.
52. Salido, E. M. Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of earlytype 2 diabetes in rats / E. M. Salido, M. Bordone, A. De laurentus [et al.] // J. Pineal Res. – 2013. – Vol. 54. – P. 179–189.
53. Sasaki, M. Circadian rhythm of mitotic rate, retinal melatonin and immunoreactive visual pigments, and affects of melatonin on the rhythms in the Japanese quail / M. Sasaki, A. Masuda, T. Oishi // J. Сотр. Physiol. – 1995. – Vol. 176. – P. 465–471.
54. Scher, J. MT(1) melatonin receptor in the human retina: expression and localization / J. Scher, E. Wankiewicz, G. M. Brown // Invest. Ophthalmol. Sci. – 2002. – Vol. 43. – P. 889–897.
55. Siu, A. W. Protective effects of melatonin in experimental free radical-related ocular diseases / A. W. Siu, M. Maldonado, M. Sanchez-Hidaldo // J. Pineal Res. – 2006. – Vol. 40. – P. 101–109.
56. Stefanova, N. A. Potential of melatonin for prevention of age-related macular degeneration: experimental study / N. A. Stefanova, A. A. Zhdankina, A. Z. Fursova // Adv. Gerantol. – 2013. – Vol. 26. – P. 122–129.
57. Taysi, S. Melatonin reduces oxidative stress in the rat lens due to radiation-induced oxidative injury / S. Taysi, R. Memisogullari, M. Koc [et al.] // Int. J. Radiat. Biol. – 2008. – Vol. 84. – P. 803–808.
58. Tok, L. Effects of melatonin on Wi-Fi-induced oxidative stress in lens of rats / L. Tok, M. Naziroglu, S. Dogan [et al.] // Indian. J. Ophthalmol. – 2014. – Vol. 62. – P. 12–15.
59. Tosini, G. Melatonin: an underappreciated player in retinal physiology and pathophysiology / G. Tosini, K. Baba, C. K. Hwang // Exp. Eye Res. – 2012. – Vol. 193. – P. 82–89.
60. Tosini, G. Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma? / G. Tosini, M. Iuvone, J. H. Boatright // J. Glaucoma. – 2013. – Vol. 22. –P. S49–S50.
61. Wahl, C. The effects of light regimes and hormones on corneal growth in vivo and in organ culture / C. Wahl, T. Li, Y. Takagi // J. Anat. – 2011. – Vol. 219. – P. 766–775.
62. Wiechmann, A. F. Melatonin receptor expression in Xenopus laevis surface corneal epithelium: diurnal rhythm of lateral membrane localization / A. F. Wiechmann, L. H. Hollaway, J. A. Rada // Mol. Vis. – 2006. – Vol. 17. – P. 2384–2403.
63. Wiechmann, A. F. Melatonin receptors are anatomically organized to modulate transmission specifically to cone pathways in the retina of Xenopus laevis / A. F. Wiechmann, D. M. Sherry // J. Сотр. Neurol. – 2012. – Vol. 520. – P. 1115–1127.
65. Wiechmann, A. F. Role of melatonin and its receptors in the vertebrate retina / A. F. Wiechmann, D. M. Sherry // Int. Rev. Cell Mol. Biol. – 2013. – Vol. 300. – P. 211–242.
65. Yagci, R. Use of melatonin to prevent selenite-induced cataract formation in rat eyes / R. Yagci, B. Aydin, M. Erdurmus [et al.] // Curr. Eye Res. – 2008. – Vol. 31. – P. 845–850.
66. Yi, С. Effects of melatonin in age-related macular degeneration / C. Yi, X. Pan, H. Yan [et al.] // Ann. N. Y. Acad. Sci. – 2005. – Vol. 1057. – P. 384–392.
67. Zhang, R. Melatonin reprogrammes proteomic profile in light-exposed retina in vivo / R. Zhang, W. J. Hrushesky, P. A. Wood [et al.] // Int. J. Biol. Macromol. – 2010. – Vol. 47. – P. 233–260.
68. Zmilewski, M. A. The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19) / M. A. Zmilewski, T. W. Sweatman, A. T. Slominski // Mol. Cell Endocrinol. – 2008. – Vol. 307. – P. 211–218.
Ключевые слова: глаз, сетчатка, мелатонин, эпифиз
Учредители:
Ставропольская государственная медицинская академия
Государственный научно-исследовательский институт курортологии
Пятигорская государственная фармацевтическая академия